Newsroom
March 4, 2024
Novel Biomarkers in Kidney Transplant: A Focus on Gene Expression Testing
Preliminary results are available from a study examining gene expression testing as a tool for managing immunosuppression in organ transplant patients….
February 5, 2024
Using Gene Expression Profile Biomarkers as an Immunosuppression Guide in Post-Transplant Care
Dr. John Friedewald serves as Medical Director of Kidney Transplantation at Northwestern Memorial Hospital and is a Professor of Medicine…
December 27, 2023
TRANSPLANT GENOMICS APPROVED AS MEDI-CAL PARTICIPATING PROVIDER
California’s Medicaid grants TGI participating provider status effective June 5, 2023, providing Medi-Cal patients access to non-invasive rejection testing with…
October 10, 2023
TRANSPLANT GENOMICS RECEIVES GEISINGER HEALTH PLAN COVERAGE FOR TRUGRAF AND VIRACOR TRAC KIDNEY TESTS
Humana’s kidney transplant patients are covered effective January 30, 2023, for non-invasive rejection testing with the TruGraf® blood gene expression…
July 19, 2022
Third Circuit Court of Appeals Affirms Judgment in Favor of Eurofins Viracor in Patent Infringement Case
LEE’S SUMMIT, MO [July 19, 2022] – Eurofins Viracor, a leader in infectious disease, immunology, and allergy testing, announced today that…
February 1, 2022
Transplant Genomics Welcomes Chief Medical Officer Jon Friedman, MD, FAST
Dr. Friedman brings 30 years of success in delivering value for patients, healthcare providers, and payors to help Transplant Genomics…
November 8, 2021
AJT Article Validates Clinical Utility of Donor-Derived Cell-Free DNA in Detecting Liver Rejection
FRAMINGHAM, MA [8 November 2021] — Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide,…
November 3, 2021
CJASN Publishes Study Validating the Combination of Biomarkers for Improved Detection of Kidney Rejection
FRAMINGHAM, MA [3 November 2021] — Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide,…
November 1, 2021
Eurofins Transplant Genomics Enrolls 500th Patient in TRULO Observational Study
Prospective, multi-center clinical study is the first to evaluate the long-term post-transplant clinical outcomes of kidney transplant recipients. FRAMINGHAM, MA…
August 16, 2021
Eurofins Transplant Genomics Announces 2021-2022 Scientific Advisory Board
Leading transplant surgeons, nephrologists, and scientists help guide Eurofins in the development of novel diagnostics to address unmet needs in…